| All | Responders | Non-responders | p value |
---|---|---|---|---|
n = 50 | n = 30 | n = 20 | ||
Age, year | 74.9 ± 5.7 | 74.6 ± 5.8 | 75.3 ± 5.7 | 0.95 |
Gender, male/female (%) | 44/6 (88/12) | 28/2 (93/7) | 16/4 (81/19) | 0.16 |
BMI, kg/m2 | 22.1 ± 3.6 | 22.0 ± 2.8 | 22.3 ± 4.7 | 0.80 |
GOLD (I + II/III/IV) | 27/17/6 | 20/8/2 | 7/9/4 | 0.07 |
LTOT, n (%) | 5 (10) | 3 (10) | 2 (10) | 0.89 |
CAT | 14 (10–20) | 11.5 (8.8–16.8) | 18.5 (12.3–20.8) | 0.04 |
FVC %predicted | 93.0 ± 20.2 | 97.3 ± 19.5 | 86.4 ± 20.0 | 0.06 |
FEV1 %predicted | 56.0 ± 21.8 | 63.2 ± 21.8 | 45.1 ± 17.1 | 0.003 |
SpO2, % | 90 ± 7 | 91 ± 7 | 90 ± 6 | 0.55 |
%LAA | 17.5 ± 16.3 | 17.0 ± 14.6 | 18.2 ± 19.0 | 0.65 |
6MWD, m | 378 ± 88 | 411 ± 83 | 328 ± 71 | < 0.001 |
mBorg scale dyspnoea | 5 (4–7) | 4 (3–7) | 6 (4–8) | 0.007 |
mBorg scale leg fatigue | 2 (1–5) | 2 (0.9–4) | 2.5 (1.3–5) | 0.50 |
PImax, cmH2O | 55.7 ± 21.9 | 65.7 ± 19.4 | 40.6 ± 16.2 | < 0.001 |
DEmax, mm | 47.9 ± 9.3 | 52.9 ± 7.8 | 40.4 ± 5.3 | < 0.001 |
QMS, kgf/kg | 0.54 ± 0.14 | 0.58 ± 0.13 | 0.48 ± 0.13 | 0.007 |